IL1B and Parkinson disease: In addition, inhibiting the activation of the NLRP3 inflammasome in astrocytes and the subsequent production of IL-1β has been found to have neuroprotective effects, confirming the central role of these cytokines in the pathogenesis of PD (Pike et al., 2022).